EUVIMEDEUVIMED entdecken
Crossref

Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study

Kazumasa Torimoto iD, Tomohiro Ueda, Daisuke Gotoh, Kuniyuki Kano, Makito Miyake, Yasushi Nakai, Shunta Hori, Yosuke Morizawa, Kenta Onishi, Takuto Shimizu, Mitsuru Tomizawa, Junken Aoki und 1 weitere

LUTS: Lower Urinary Tract Symptoms · 2023

DOI: 10.1111/luts.12501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, 2023. Verfasst von Kazumasa Torimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Nara, Japan. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Urinary Bladder, Overactive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Grant-in-Aid for Scientific Research (C).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Diagnosing interstitial cystitis/bladder pain syndrome presents a major challenge because it relies on subjective symptoms and empirical cystoscopic findings. A practical biomarker should discriminate diseases that cause increased urinary frequency, particularly overactive bladder. Therefore, we aimed to identify blood biomarkers that can discriminate between interstitial cystitis/bladder pain syndrome and overactive bladder.

Methods

We enrolled patients with Hunner‐type interstitial cystitis ( n = 20), bladder pain syndrome ( n = 20), and overactive bladder ( n = 20) and without lower urinary tract symptoms (controls, n = 15) at Ueda Clinic and Nara Medical University Hospital from February 2020 to August 2021. The degree of interstitial cystitis/bladder pain syndrome symptoms was evaluated using the interstitial cystitis symptom and problem indices. Metabolomics analysis was performed on 323 serum metabolites using liquid chromatography time‐of‐flight mass spectrometry.

Results

In the Hunner‐type interstitial cystitis or bladder pain syndrome group, we observed smaller relative areas, including anandamide, acylcarnitine (18:2), linoleoyl ethanolamide, and arachidonic acid, compared to those in the overactive bladder or control group. Notably, the differences in the relative areas of anandamide were statistically significant (median: 3.950e‐005 and 4.150e‐005 vs. 8.300e‐005 and 9.800e‐005), with an area under the curve of 0.9321, demonstrating its ability to discriminate interstitial cystitis/bladder pain syndrome.

Conclusions

Serum anandamide may be a feasible diagnostic biomarker for interstitial cystitis/bladder pain syndrome. Reduced serum anandamide levels may be associated with pain and inflammation initiation, reflecting the pathology of interstitial cystitis/bladder pain syndrome. Furthermore, our findings suggest that abnormal linoleic acid metabolism may be involved in the pathogenesis of interstitial cystitis/bladder pain syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystitis, InterstitialUrinary Bladder, OveractiveHumansLinoleic AcidPelvic PainBiomarkersArachidonic AcidsPolyunsaturated AlkamidesEndocannabinoids

Stichwörter der Autor:innen

anandamidebladder pain syndromeendocannabinoidinterstitial cystitislinoleic acid

Substanzen

Linoleic AcidBiomarkersanandamideArachidonic AcidsPolyunsaturated AlkamidesEndocannabinoids

Autor:innen und Institutionen

  • Department of Urology, Nara Medical University, Nara, Japan.
  • Ueda Clinic, Kyoto, Japan.
  • Department of Health Chemistry, Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Kazumasa Torimoto, Kiyohide Fujimoto

Förderung

  • Grant-in-Aid for Scientific Research (C)

Zitieren

APA

Torimoto, K., Ueda, T., Gotoh, D., Kano, K., Miyake, M., Nakai, Y., Hori, S., Morizawa, Y., Onishi, K., Shimizu, T., Tomizawa, M., Aoki, J., & Fujimoto, K. (2023). Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.12501

Vancouver

Torimoto K, Ueda T, Gotoh D, Kano K, Miyake M, Nakai Y, et al. Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study. LUTS: Lower Urinary Tract Symptoms. 2023. doi:10.1111/luts.12501

BibTeX
@article{Torimoto2023,
  author = {Torimoto, Kazumasa and Ueda, Tomohiro and Gotoh, Daisuke and Kano, Kuniyuki and Miyake, Makito and Nakai, Yasushi and Hori, Shunta and Morizawa, Yosuke and Onishi, Kenta and Shimizu, Takuto and Tomizawa, Mitsuru and Aoki, Junken and Fujimoto, Kiyohide},
  title = {Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2023},
  doi = {10.1111/luts.12501}
}
Kostenlos starten →